FDA ALERT: FDA APPROVES FIRST GENERIC VERSION OF EPIPEN
The U.S. Food and Drug Administration (FDA) today approved the first generic version of EpiPen and EpiPen Jr auto-injector for the emergency treatment of allergic reactions, including those that are life-threatening, in adults and pediatric patients who weigh more than 33 pounds. Read the FDA's announcement.
Bookmark Your Most Used Pages on the AAAAI Website
Do you have pages you use often on the AAAAI website but do not want to click through each time to access them? Now, when you are logged in, the My Membership homepage features a bookmark section that will allow you to easily access your most used pages. Click here for instructions.
Add the American Board of Allergy and Immunology (ABAI) website to your "My Favorites" section of the My Membership page.